E-therapeutics Regulatory News (ETX)

e-Therapeutics plc (AIM: ETX)

Notification of Half Year Results Date

Oxford and Newcastle, UK, 04 September 2014 - e-Therapeutics plc (AIM: ETX), the drug discovery and development company with a proprietary platform in network pharmacology, will be announcing its half year results for the period ended 31 July 2014 on Tuesday, 16 September 2014.

A group analyst briefing will be held on the same day at 11:30am at Instinctif Partners' offices at 65 Gresham Street, London EC2V 7NQ.

- Ends -

Contacts:

e-Therapeutics plc

Steve Medlicott

Tel: +44 (0) 1993 880000

www.etherapeutics.co.uk 

N+1 Singer

Aubrey Powell / Jen Boorer

Tel: +44 (0)20 7496 3000

www.n1singer.com 

Instinctif Partners

Melanie Toyne Sewell / Emma Barlow

Tel: +44 (0) 20 7457 2020

Email: e-therapeutics@instinctif.com